Astrazeneca (AZN) closed higher, showing significant growth and positive estimate revisions.

From Nasdaq: 2024-12-20 18:15:10

In the latest trading session, Astrazeneca (AZN) closed at $65.35, up 1.41% from the previous day, outpacing the S&P 500. Analysts expect Astrazeneca to report earnings of $1.06 per share with revenue of $14.26 billion, showing significant growth. The Zacks Rank system rates AZN as a Hold with positive estimate revisions.

Astrazeneca’s valuation shows a Forward P/E ratio of 15.67, higher than the industry average. The company also has a PEG ratio of 1.15, indicating potential growth. The Large Cap Pharmaceuticals industry ranks in the bottom 38%, but Zacks Industry Rank data suggests top industries outperform the rest.

Zacks has identified a top semiconductor stock with massive growth potential in AI, ML, and IoT. With the semiconductor market set to grow from $452 billion to $803 billion by 2028, this stock offers a strong opportunity for investors. Visit Zacks.com for more insights on this stock and others for upcoming trading sessions.



Read more at Nasdaq: Why Astrazeneca (AZN) Outpaced the Stock Market Today